Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation
Wen Yao, Xinchen Fang, Peng Jiang, Juan Tong, Liangquan Geng, Xiaoyu Zhu, Baolin Tang, Xiang Wan, Kaidi Song, Lei Zhang, Ping Qiang, Guangyu Sun, Yongsheng Han, Huilan Liu, Zimin Sun
Abstract
To the
Topics & Concepts
MedicineMyeloid leukemiaCytarabineCancer researchBridging (networking)Hematopoietic stem cell transplantationHaematopoiesisTransplantationStem cellLeukemiaOncologyImmunologyGranulocyte colony-stimulating factorMyeloidHematopoietic cellInternal medicineHematopoietic stem cellConditioning regimenHematologyAutologous stem-cell transplantationAcute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia research